StockDriftsStockDriftsTop 50 Adar1 Capital Management LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA | 11.3% | 1.80M | $240.5M | +29.46%(+410.68K) | $38.27(+210.88%) | 2026-06-30 | |
| PTGX | PROTAGONIST THERAPEUTICS INC | 5.54% | 960.9K | $117.8M | -3.35%(-33.26K) | $32.88(+371.73%) | 2026-06-30 | |
| ROIV | ROIVANT SCIENCES LTD | 5.25% | 3.16M | $111.7M | -3.92%(-128.90K) | $12.11(+198.99%) | 2026-06-30 | |
| SPY | STATE STR SPDR S&P 500 ETF T | 4.53% | 129.1K | $96.4M | +69.99%(+53.15K) | $655.77(+18.39%) | 2026-06-30 | |
| IMVT | IMMUNOVANT INC | 4.22% | 2.33M | $89.8M | -13.00%(-348.29K) | $19.41(+115.48%) | 2026-06-30 | |
| ZLAB | ZAI LAB LTD | 3.01% | 3.37M | $64.0M | +136.36%(+1.94M) | $20.48(+26.46%) | 2026-06-30 | |
| AGIO | AGIOS PHARMACEUTICALS INC | 2.25% | 1.29M | $47.8M | +815.64%(+1.15M) | $33.50(+0.17%) | 2026-06-30 | |
| CRNX | CRINETICS PHARMACEUTICALS IN | 2.15% | 1.22M | $45.7M | +7.26%(+82.75K) | $40.40(+109.66%) | 2026-06-30 | |
| BOXX | EA SERIES TRUST | 1.86% | 337.1K | $39.5M | +0.00%(+0) | $106.13(+11.07%) | 2026-06-30 | |
| CYTK | CYTOKINETICS INC | 1.83% | 457.9K | $39.0M | -27.61%(-174.65K) | $57.34(+29.28%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (10 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | +260.19% |
| Top 20 Holdings Unweighted | — | — | — | — | +180.06% |
Adar1 Capital Management LLC reports $2.19B in US-listed equity holdings across 267 positions in its most recent 13F filing. Its largest disclosed positions are ABVX (11.3%), PTGX (5.5%) and ROIV (5.3%). The top 20 holdings account for 54.29% of reported assets. Its disclosed equity book has returned +260.19% cumulatively over 10 quarters. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Adar1 Capital Management LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Adar1 Capital Management LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1940272). View Adar1 Capital Management LLC’s 13F filings on SEC